Outcomes of Patients with Metastatic Melanoma—A Single-Institution Retrospective Analysis

Outcomes of Patients with Metastatic Melanoma—A Single-Institution Retrospective Analysis

Background: This study assessed risk factors and the results of treatment with anti-PD-1 antibodies and BRAF/MEK inhibitors for advanced malignant melanoma. Methods: A retrospective analysis was performed on 52 patients treated with immunotherapy and BRAF/MEK inhibitors for disseminated malignant me...

Full description

Bibliographic Details
Main Authors: Lidia Szatkowska, Jan Sieczek, Katarzyna Tekiela, Marcin Ziętek, Paulina Stachyra-Strawa, Paweł Cisek, Rafał Matkowski
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
melanoma
treatment
prognosis
PD-1
PD-L1
CTLA4
Online Access:https://www.mdpi.com/2072-6694/14/7/1672

Internet

https://www.mdpi.com/2072-6694/14/7/1672

Similar Items